Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study

Summary: Background: Lung disease is a common comorbidity in people with HIV/AIDS, independent of smoking status. The effects of marijuana smoking on risk of lung disease in HIV-infected individuals are unclear. Methods: In this prospective cohort study, we quantified lung disease risk among men en...

Full description

Bibliographic Details
Main Authors: David R. Lorenz, Hajime Uno, Steven M. Wolinsky, Dana Gabuzda
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537019300033
id doaj-bad55429eba44df9a81a0a460a543df4
record_format Article
spelling doaj-bad55429eba44df9a81a0a460a543df42020-11-24T23:31:33ZengElsevierEClinicalMedicine2589-53702019-01-0175564Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort StudyDavid R. Lorenz0Hajime Uno1Steven M. Wolinsky2Dana Gabuzda3Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USACenter for Population Science, Dana-Farber Cancer Institute, Boston, MA, USADivision of Infectious Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USADepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Corresponding author at: Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Center for Life Science 1010, 450 Brookline Avenue, Boston, MA 02215, USA.Summary: Background: Lung disease is a common comorbidity in people with HIV/AIDS, independent of smoking status. The effects of marijuana smoking on risk of lung disease in HIV-infected individuals are unclear. Methods: In this prospective cohort study, we quantified lung disease risk among men enrolled in the Multicenter AIDS Cohort Study (MACS), a long-term observational cohort of HIV-infected and uninfected men who have sex with men. Eligible participants were aged ≥30 years with self-reported marijuana and tobacco smoking data from biannual study visits between 1996 and 2014. Pulmonary diagnoses were obtained from self-report and medical records. Analyses were performed using Cox models and Generalized Estimating Equations adjusted for tobacco smoking, CD4 T cell count, and other risk factors. Findings: 1630 incident pulmonary diagnoses were reported among 1352 HIV-seropositive and 1352 HIV-seronegative eligible participants matched for race and baseline age (53,794 total person-visits, median follow-up 10.5 years). 27% of HIV-infected participants reported daily or weekly marijuana smoking for one or more years in follow-up, compared to 18% of uninfected participants (median 4·0 and 4·5 years daily/weekly use, respectively). HIV-infected participants had an increased likelihood of infectious or non-infectious pulmonary diagnoses compared to uninfected participants (33·2% vs. 21·5%, and 20·6% vs. 17·2%, respectively). Among HIV-infected participants, recent marijuana smoking was associated with increased risk of infectious pulmonary diagnoses and chronic bronchitis independent of tobacco smoking and other risk factors for lung disease (hazard ratio [95% confidence interval] 1·43 [1·09–1·86], and 1·54 [1·11–2·13], respectively); these risks were additive in participants smoking both substances. There was no association between marijuana smoking and pulmonary diagnoses in HIV-uninfected participants. Interpretation: In this longitudinal study, long-term marijuana smoking was associated with lung disease independent of tobacco smoking and other risk factors in HIV-infected individuals. These findings could be used to reduce modifiable risks of lung disease in high-risk populations. Funding: U.S. National Institutes of Health.http://www.sciencedirect.com/science/article/pii/S2589537019300033
collection DOAJ
language English
format Article
sources DOAJ
author David R. Lorenz
Hajime Uno
Steven M. Wolinsky
Dana Gabuzda
spellingShingle David R. Lorenz
Hajime Uno
Steven M. Wolinsky
Dana Gabuzda
Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study
EClinicalMedicine
author_facet David R. Lorenz
Hajime Uno
Steven M. Wolinsky
Dana Gabuzda
author_sort David R. Lorenz
title Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study
title_short Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study
title_full Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study
title_fullStr Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study
title_full_unstemmed Effect of Marijuana Smoking on Pulmonary Disease in HIV-Infected and Uninfected Men: A Longitudinal Cohort Study
title_sort effect of marijuana smoking on pulmonary disease in hiv-infected and uninfected men: a longitudinal cohort study
publisher Elsevier
series EClinicalMedicine
issn 2589-5370
publishDate 2019-01-01
description Summary: Background: Lung disease is a common comorbidity in people with HIV/AIDS, independent of smoking status. The effects of marijuana smoking on risk of lung disease in HIV-infected individuals are unclear. Methods: In this prospective cohort study, we quantified lung disease risk among men enrolled in the Multicenter AIDS Cohort Study (MACS), a long-term observational cohort of HIV-infected and uninfected men who have sex with men. Eligible participants were aged ≥30 years with self-reported marijuana and tobacco smoking data from biannual study visits between 1996 and 2014. Pulmonary diagnoses were obtained from self-report and medical records. Analyses were performed using Cox models and Generalized Estimating Equations adjusted for tobacco smoking, CD4 T cell count, and other risk factors. Findings: 1630 incident pulmonary diagnoses were reported among 1352 HIV-seropositive and 1352 HIV-seronegative eligible participants matched for race and baseline age (53,794 total person-visits, median follow-up 10.5 years). 27% of HIV-infected participants reported daily or weekly marijuana smoking for one or more years in follow-up, compared to 18% of uninfected participants (median 4·0 and 4·5 years daily/weekly use, respectively). HIV-infected participants had an increased likelihood of infectious or non-infectious pulmonary diagnoses compared to uninfected participants (33·2% vs. 21·5%, and 20·6% vs. 17·2%, respectively). Among HIV-infected participants, recent marijuana smoking was associated with increased risk of infectious pulmonary diagnoses and chronic bronchitis independent of tobacco smoking and other risk factors for lung disease (hazard ratio [95% confidence interval] 1·43 [1·09–1·86], and 1·54 [1·11–2·13], respectively); these risks were additive in participants smoking both substances. There was no association between marijuana smoking and pulmonary diagnoses in HIV-uninfected participants. Interpretation: In this longitudinal study, long-term marijuana smoking was associated with lung disease independent of tobacco smoking and other risk factors in HIV-infected individuals. These findings could be used to reduce modifiable risks of lung disease in high-risk populations. Funding: U.S. National Institutes of Health.
url http://www.sciencedirect.com/science/article/pii/S2589537019300033
work_keys_str_mv AT davidrlorenz effectofmarijuanasmokingonpulmonarydiseaseinhivinfectedanduninfectedmenalongitudinalcohortstudy
AT hajimeuno effectofmarijuanasmokingonpulmonarydiseaseinhivinfectedanduninfectedmenalongitudinalcohortstudy
AT stevenmwolinsky effectofmarijuanasmokingonpulmonarydiseaseinhivinfectedanduninfectedmenalongitudinalcohortstudy
AT danagabuzda effectofmarijuanasmokingonpulmonarydiseaseinhivinfectedanduninfectedmenalongitudinalcohortstudy
_version_ 1725537380179378176